Recall of textured breast implant

In July 2019, the Therapeutic Goods Administration proposed cancellation of Allergan macro-textured breast implants and tissue expanders due to higher risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), compared to other implants.

In July 2019, the Therapeutic Goods Administration proposed cancellation of Allergan macro-textured breast implants and tissue expanders due to higher risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), compared to other implants.

Allergen has now announced a voluntary recall of BIOCELL macro-textured breast implants and tissue expanders. 
BIA-ALCL is a rare type of lymphoma that has been reported in a number of people with a textured breast implant. The main symptoms of BIA-ALCL include swelling in the breast, and less commonly, lump formation in the breast or armpit.  

What you need to do

Any person who has a breast implant should self-examine regularly and be aware of potential BIA-ALCL symptoms.

Because BIA-ALCL is rare, experts do not recommend removal of breast implants where there are no problems with the implant. Testing for BIA-ALCL is only recommended if symptoms are present.

If you have any concerns, or notice any changes in your breasts, speak with your General Practitioner (GP) or surgeon.

More information

The Therapeutic Goods Administration has updated its website in relation to its proposed cancellation of Allergan macro-textured breast implants.

Page last updated on: 16 Aug 2019